Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1CNS 1

Conditions

Head and Neck Neoplasms 2103Squamous Cell Carcinoma of Head and Neck 1654Nasopharyngeal Carcinoma 517Thyroid Neoplasms 478Carcinoma, Non-Small-Cell Lung 438Breast Neoplasms 315Mouth Neoplasms 312Neoplasms 309Melanoma 299Oropharyngeal Neoplasms 285Colorectal Neoplasms 274Lung Neoplasms 248Carcinoma, Squamous Cell 240Neoplasm Metastasis 235Ovarian Neoplasms 228Uterine Cervical Neoplasms 204Stomach Neoplasms 195Salivary Gland Neoplasms 192Laryngeal Neoplasms 192Nasopharyngeal Neoplasms 189Carcinoma, Renal Cell 183Esophageal Neoplasms 179Pancreatic Neoplasms 176Prostatic Neoplasms 158Sarcoma 142Triple Negative Breast Neoplasms 136Urinary Bladder Neoplasms 135Recurrence 128Endometrial Neoplasms 124Hypopharyngeal Neoplasms 121

Interventions

ebselen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Deafness × Head & Neck × Clear all
NCT01451853 2026-06-03

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Sound Pharmaceuticals, Incorporated

Phase 2 Withdrawn
Head & NeckThoracic

Ototoxicity, Deafness, Head and Neck Neoplasms, Lung Neoplasms, Tinnitus, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡